---
figid: PMC4037130__nihms561517f1
figlink: /pmc/articles/PMC4037130/figure/F1/
number: Figure 1
caption: Active (farnesylated, membrane-bound and GTP-bound) RAS modulates a number
  of signalling pathways. Oncogenic RAS mutations tend to lock RAS in its GTP-bound
  state, resulting in constitutive RAS signalling. The major RAS effector pathways
  are shown. The two best-studied pathways that are activated by RAS are the RAF–MEK–MAPK
  signalling cascade and the PI3K–AKT pathway. The RAF–MEK–MAPK pathway ultimately
  activates the ETS family of transcription factors, which induce multiple genes that
  promote cell cycle progression and cell migration. Likewise, AKT phosphorylates
  multiple cellular proteins, leading to the inhibition of several tumour suppressors
  (such as p27, p53, tuberous sclerosis 1 (TSC1), TSC2 and BCL-2 antagonist of cell
  death (BAD)) or leading to the activation of several oncogene products. RAS also
  activates other small GTPases such as RALA and RALB, which have recently been shown
  to mediate RAS transformation in human pancreatic tumours, for example. Farnesyltransferase
  inhibitors (FTIs) were originally developed to block the function of RAS. However,
  as numerous studies in vitro and in vivo have shown, their antitumour activity is
  not correlated to the mutation status of KRAS isoforms. This suggests that the antitumour
  activity of FTIs relies on blocking the activity of other prenylated proteins. However,
  the inhibition of RAS protein function may still be important, particularly for
  tumours with mutant HRAS and tumours addicted to wild-type RAS. CDC42, cell division
  cycle 42; DAG, diacylglycerol; FOX, forkhead transcription factor; GAP, GTPase-activating
  protein; GEF, guanine nucleotide exchange factor; IKK, IκB kinase; IP3, inositol-1,4,5-trisphosphate;
  mTORC, mTOR complex; NF-κB, nuclear factor-κB; PDK1, phosphoinositide-dependent
  kinase 1; PKC, protein kinase C; PLA, phospholipase A; PLCε, phospholipase Cε; PLD,
  phospholipase D; RALGDS, RAL guanine nucleotide dissociation stimulator; RHEB, RAS
  homologue enriched in brain; RIN1, RAS and RAB interactor 1; TIAM1, T cell lymphoma
  invasion and metastasis 1.
pmcid: PMC4037130
papertitle: Targeting protein prenylation for cancer therapy.
reftext: Norbert Berndt, et al. Nat Rev Cancer. ;11(11):775-791.
pmc_ranked_result_index: '89771'
pathway_score: 0.9245159
filename: nihms561517f1.jpg
figtitle: Targeting protein prenylation for cancer therapy
year: ''
organisms: Homo sapiens
ndex: a729f3b8-df0b-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4037130__nihms561517f1.html
  '@type': Dataset
  description: Active (farnesylated, membrane-bound and GTP-bound) RAS modulates a
    number of signalling pathways. Oncogenic RAS mutations tend to lock RAS in its
    GTP-bound state, resulting in constitutive RAS signalling. The major RAS effector
    pathways are shown. The two best-studied pathways that are activated by RAS are
    the RAF–MEK–MAPK signalling cascade and the PI3K–AKT pathway. The RAF–MEK–MAPK
    pathway ultimately activates the ETS family of transcription factors, which induce
    multiple genes that promote cell cycle progression and cell migration. Likewise,
    AKT phosphorylates multiple cellular proteins, leading to the inhibition of several
    tumour suppressors (such as p27, p53, tuberous sclerosis 1 (TSC1), TSC2 and BCL-2
    antagonist of cell death (BAD)) or leading to the activation of several oncogene
    products. RAS also activates other small GTPases such as RALA and RALB, which
    have recently been shown to mediate RAS transformation in human pancreatic tumours,
    for example. Farnesyltransferase inhibitors (FTIs) were originally developed to
    block the function of RAS. However, as numerous studies in vitro and in vivo have
    shown, their antitumour activity is not correlated to the mutation status of KRAS
    isoforms. This suggests that the antitumour activity of FTIs relies on blocking
    the activity of other prenylated proteins. However, the inhibition of RAS protein
    function may still be important, particularly for tumours with mutant HRAS and
    tumours addicted to wild-type RAS. CDC42, cell division cycle 42; DAG, diacylglycerol;
    FOX, forkhead transcription factor; GAP, GTPase-activating protein; GEF, guanine
    nucleotide exchange factor; IKK, IκB kinase; IP3, inositol-1,4,5-trisphosphate;
    mTORC, mTOR complex; NF-κB, nuclear factor-κB; PDK1, phosphoinositide-dependent
    kinase 1; PKC, protein kinase C; PLA, phospholipase A; PLCε, phospholipase Cε;
    PLD, phospholipase D; RALGDS, RAL guanine nucleotide dissociation stimulator;
    RHEB, RAS homologue enriched in brain; RIN1, RAS and RAB interactor 1; TIAM1,
    T cell lymphoma invasion and metastasis 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - PRKCZ
  - MTOR
  - RICTOR
  - MLST8
  - PLCE1
  - PRKCI
  - PDK1
  - MAPKAP1
  - RALB
  - MAPK13
  - PRKCQ
  - MDM2
  - NFKB1
  - PIK3CD
  - PIK3CG
  - RPTOR
  - MAP2K1
  - PLD3
  - TP53
  - MAPK11
  - KRAS
  - MAPK10
  - PIK3R5
  - BAD
  - CDC42
  - ETS1
  - ETS2
  - CHUK
  - PLD4
  - PLD5
  - NRAS
  - RHEB
  - RHO
  - MAPK9
  - PIK3R6
  - RAC1
  - ARAF
  - MAPK12
  - BRAF
  - RALA
  - TSC2
  - RALGDS
  - HRAS
  - PLD6
  - MAPK1
  - MAPK3
  - RIN1
  - PLD2
  - TIAM1
  - TSC1
  - PIK3R4
  - PIK3CA
  - PIK3CB
  - MAPK14
  - PRKCH
  - IKBKB
  - IKBKG
  - PRKCG
  - PRKCE
  - MAPK8
  - PLD1
  - PRKCD
  - PIK3R3
  - AKT2
  - RAF1
  - AKT1
  - PRKCB
  - AKT3
  - MTTP
  - PRKD3
  - PRKCA
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MEK2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: PLCE
  symbol: PLCE
  source: hgnc_alias_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: RAL
  symbol: RAL
  source: bioentities_symbol
  hgnc_symbol: RALB
  entrez: '5899'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: MDM2
  symbol: MDM2
  source: hgnc_symbol
  hgnc_symbol: MDM2
  entrez: '4193'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MEK1
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD3
  entrez: '23646'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: CDC42
  symbol: CDC42
  source: hgnc_symbol
  hgnc_symbol: CDC42
  entrez: '998'
- word: ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS1
  entrez: '2113'
- word: ETS
  symbol: ETS
  source: bioentities_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: (IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: CHUK
  entrez: '1147'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD4
  entrez: '122618'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD5
  entrez: '200150'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RHEB
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: RHO
  symbol: RHO
  source: hgnc_symbol
  hgnc_symbol: RHO
  entrez: '6010'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAC1
  symbol: RAC1
  source: hgnc_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAL
  symbol: RAL
  source: bioentities_symbol
  hgnc_symbol: RALA
  entrez: '5898'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: RALGDS
  symbol: RALGDS
  source: hgnc_symbol
  hgnc_symbol: RALGDS
  entrez: '5900'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD6
  entrez: '201164'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RIN1
  symbol: RIN1
  source: hgnc_symbol
  hgnc_symbol: RIN1
  entrez: '9610'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD2
  entrez: '5338'
- word: TIAM1
  symbol: TIAM1
  source: hgnc_symbol
  hgnc_symbol: TIAM1
  entrez: '7074'
- word: TSC1
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: (IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKB
  entrez: '3551'
- word: (IKK
  symbol: IKK
  source: bioentities_symbol
  hgnc_symbol: IKBKG
  entrez: '8517'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD1
  entrez: '5337'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ABL
  symbol: ABL
  source: hgnc_alias_symbol
  hgnc_symbol: MTTP
  entrez: '4547'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
